Literature DB >> 9755230

Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.

K Noda1, E Miyoshi, N Uozumi, S Yanagidani, Y Ikeda, C Gao, K Suzuki, H Yoshihara, K Yoshikawa, K Kawano, N Hayashi, M Hori, N Taniguchi, M Yoshikawa.   

Abstract

The 1-6 fucosylated -fetoprotein (AFP) present in serum of patients with hepatocellular carcinoma (HCC) has been employed for the differential clinical diagnosis of HCC from chronic liver diseases. The molecular mechanism by which this alteration occurs, however, remains largely unknown. To address this issue, we purified GDP-L-Fuc:N-acetyl-beta-D-glucosaminide 1-6 fucosyltransferase (1-6 FucT), an enzyme involved in the 1-6 fucosylation of N-glycans from porcine brain, as well as from a human gastric cancer cell line, and cloned their genes. In this study, levels of 1-6 FucT mRNA expression and the activity of this enzyme for 12 human HCC tissues were examined and compared with that in surrounding tissues and normal livers. The mean +/- SD for 1-6 FucT activity was 78 +/- 41 pmol/h/mg in normal control liver, 202 +/- 127 pmol/h/mg in adjacent uninvolved liver tissues (chronic hepatitis: 181 +/- 106 pmol/h/mg; liver cirrhosis: 233 +/- 164 pmol/h/mg), and 195 +/- 72 pmol/h/mg in HCC tissues. The mRNA expression of 1-6 FucT was also enhanced in proportion to enzymatic activity except for a few cases, suggesting that 1-6 FucT expression is increased in chronic liver diseases, especially liver cirrhosis. Transfection of 1-6 FucT gene into cultured rat hepatocytes markedly increased 1-6 FucT activity and led to an increase in lens culinaris agglutinin (LCA) binding proteins in both cell lysates and condition media. When the 1-6 FucT gene was transfected into a human HCC cell line, Hep3B, which originally showed low levels of 1-6 FucT expression, 1-6-fucosylated AFP was dramatically increased in the condition media. Collectively, these results suggest that the enhancement of 1-6 FucT expression increased the fucosylation of several proteins, including AFP, and that the level of 1-6-fucosylated AFP in patients with HCC was in part caused by up-regulation of the 1-6 FucT gene expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755230     DOI: 10.1002/hep.510280408

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  28 in total

Review 1.  Serum markers of hepatocellular carcinoma.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Massimiliano Berretta; Alessandro Cappellani; Mariano Malaguarnera
Journal:  Dig Dis Sci       Date:  2010-03-26       Impact factor: 3.199

Review 2.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

3.  Capturing and identification of differentially expressed fucome by a gel free and label free approach.

Authors:  Chanida Puangpila; Ziad El Rassi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-03-14       Impact factor: 3.205

4.  Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.

Authors:  Amr Amin; Asma Bashir; Nazar Zaki; Diane McCarthy; Sanjida Ahmed; Mohamed Lotfy
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 5.  Protein glycosylation in cancer.

Authors:  Sean R Stowell; Tongzhong Ju; Richard D Cummings
Journal:  Annu Rev Pathol       Date:  2015       Impact factor: 23.472

6.  Recent advances in mass spectrometry (MS)-based glycoproteomics in complex biological samples.

Authors:  Zhengwei Chen; Junfeng Huang; Lingjun Li
Journal:  Trends Analyt Chem       Date:  2018-10-15       Impact factor: 12.296

7.  Fucosylation and gastrointestinal cancer.

Authors:  Kenta Moriwaki; Eiji Miyoshi
Journal:  World J Hepatol       Date:  2010-04-27

Review 8.  Glycosylation in cancer: mechanisms and clinical implications.

Authors:  Salomé S Pinho; Celso A Reis
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

9.  Inhibiting post-translational core fucosylation protects against albumin-induced proximal tubular epithelial cell injury.

Authors:  Dapeng Wang; Ming Fang; Nan Shen; Longkai Li; Weidong Wang; Lingyu Wang; Hongli Lin
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

10.  Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma.

Authors:  Haidi Yin; Zhijing Tan; Jing Wu; Jianhui Zhu; Kerby A Shedden; Jorge Marrero; David M Lubman
Journal:  J Proteome Res       Date:  2015-10-02       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.